Abstract
Psoriasis is a common chronic inflammatory disease of the skin affecting approximately 2% of Caucasians. Psoriasis has a worldwide distribution, with prevalence varying according to race and geographic location. Numerous population-, family- and twin-based studies point to a very strong genetic component of this disease. Psoriasis is a complex disease, as suggested by a very unclear and variable pattern of inheritance and a higher frequency in families of dizygotic twins than in those of monozygotic twins. So far 9 psoriasis susceptibility loci have been identified (PSORS1-9) but only three (PSORS1, PSORS2 and PSORS4) have been replicated in more than one study. The strongest genetic association has been found with the HLA-C region on the short arm of chromosome 6. Failure to reach 100% concordance in monozygotic twins points to a multifactorial aetiology of psoriasis where environmental factors play an important role in genetically predisposed individuals. Clinical, histological and ultrastructural evidence suggests that psoriasis is a T cellmediated disease where T cell activation is followed by release of pro-inflammatory cytokines, leukocytic infiltration of the skin, abnormal keratinocyte proliferation and angiogenesis. It is not known which exogenous or endogenous antigen(s) is responsible for triggering T cell activation or which genes play a fundamental role in psoriasis. Research is being carried out in an attempt to answer these questions. Here we review the main pathogenetic and epidemiological aspects of this skin condition.
Keywords: psoriasis, epidemiology, prevalence, genetics, pathogenesis, multifactorial disease
Current Genomics
Title: The Clinical Genetics of Psoriasis
Volume: 6 Issue: 1
Author(s): E. Campalani and J. N.W.N. Barker
Affiliation:
Keywords: psoriasis, epidemiology, prevalence, genetics, pathogenesis, multifactorial disease
Abstract: Psoriasis is a common chronic inflammatory disease of the skin affecting approximately 2% of Caucasians. Psoriasis has a worldwide distribution, with prevalence varying according to race and geographic location. Numerous population-, family- and twin-based studies point to a very strong genetic component of this disease. Psoriasis is a complex disease, as suggested by a very unclear and variable pattern of inheritance and a higher frequency in families of dizygotic twins than in those of monozygotic twins. So far 9 psoriasis susceptibility loci have been identified (PSORS1-9) but only three (PSORS1, PSORS2 and PSORS4) have been replicated in more than one study. The strongest genetic association has been found with the HLA-C region on the short arm of chromosome 6. Failure to reach 100% concordance in monozygotic twins points to a multifactorial aetiology of psoriasis where environmental factors play an important role in genetically predisposed individuals. Clinical, histological and ultrastructural evidence suggests that psoriasis is a T cellmediated disease where T cell activation is followed by release of pro-inflammatory cytokines, leukocytic infiltration of the skin, abnormal keratinocyte proliferation and angiogenesis. It is not known which exogenous or endogenous antigen(s) is responsible for triggering T cell activation or which genes play a fundamental role in psoriasis. Research is being carried out in an attempt to answer these questions. Here we review the main pathogenetic and epidemiological aspects of this skin condition.
Export Options
About this article
Cite this article as:
Campalani E. and Barker N.W.N. J., The Clinical Genetics of Psoriasis, Current Genomics 2005; 6 (1) . https://dx.doi.org/10.2174/1389202053202157
DOI https://dx.doi.org/10.2174/1389202053202157 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Pathophysiology and Biomarkers for Breast Cancer: Management Using Herbal Medicines
Current Nutrition & Food Science RAGE: A Multi-Ligand Receptor Unveiling Novel Insights in Health and Disease
Current Medicinal Chemistry Combination Therapy of Cisplatin and other Agents for Osteosarcoma: A Review
Current Cancer Therapy Reviews Acetylenic Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry ALK-Positive Non-Small Cell Lung Cancer; Potential Combination Drug Treatments
Current Cancer Drug Targets Thyroid Hormone Modulation of Immunity: Its Participation in Chronic Stress-Induced Immune Alterations
Current Immunology Reviews (Discontinued) 9-Hydroxyellipticine and Derivatives as Chemotherapy Agents
Mini-Reviews in Medicinal Chemistry Adjuvant and Neoadjuvant Chemotherapy for Soft Tissue Sarcomas
Current Medicinal Chemistry Angiogenesis Inhibitors and Radiation in Multimodality Cancer Therapy: Preclinical and Clinical Studies
Current Angiogenesis (Discontinued) Aspartic Protease Inhibitors as Potential Anti-Candida albicans Drugs: Impacts on Fungal Biology, Virulence and Pathogenesis
Current Medicinal Chemistry Cytochrome P450 Structure, Function and Clinical Significance: A Review
Current Drug Targets Colon Cancer Therapy: Recent Developments in Nanomedicine to Improve the Efficacy of Conventional Chemotherapeutic Drugs
Anti-Cancer Agents in Medicinal Chemistry Contrast Echocardiography: An Update on Clinical Applications
Current Pharmaceutical Design Targeting Cancer Stem Cells: Promises and Challenges
Anti-Cancer Agents in Medicinal Chemistry Structural and Mechanistic Insights of CRAC Channel as a Drug Target in Autoimmune Disorder
Current Drug Targets Phycobilins and Phycobiliproteins Used in Food Industry and Medicine
Mini-Reviews in Medicinal Chemistry Computed Tomography (CT) Features of Pelvic Rhabdomyosarcoma (RMS) in Children
Current Medical Imaging Current Understanding of HSP90 as a Novel Therapeutic Target: An Emerging Approach for the Treatment of Cancer
Current Pharmaceutical Design Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches
Current Pharmaceutical Design The Role of E-Cadherin Down-Regulation in Oral Cancer: CDH1 Gene Expression and Epigenetic Blockage
Current Cancer Drug Targets